This study systematically investigates the expression patterns, prognostic value, immune microenvironment interactions, and therapeutic targeting potential of the PLOD family in ccRCC, aiming to elucidate its molecular mechanisms in driving tumor progression and provide theoretical foundations for developing novel diagnostic and therapeutic strategies. This evidence concerns the gene PLOD1 and nonpapillary renal cell carcinoma.